Recently selected as one of five national finalists for “Entrepreneur of the Year” by Entrepreneur magazine, Kevin is a scientist-entrepreneur with 30 years of research experience in academia and pharma. His research discoveries have been published in Science, Nature and other leading scientific journals and he has eight technology patents. He is founder and CEO of Assay Depot, which owns and operates a network of online Research Exchanges that are transforming how medical research is done. He recently founded Bio, Tech and Beyond (BTnB), a non-profit community laboratory dedicated to life science research. In 2001, Kevin founded Kalypsys, a fully integrated pharmaceutical company that raised over $170 million in venture funding and put five drug candidates into human clinical trials. Prior to Kalypsys, he directed lead discovery at Tularik, a biopharmaceutical company purchased by Amgen for more than $2 billion. He carried out postdoctoral work in Cell Biology at Harvard Medical School after receiving a PhD degree from the University of California, San Francisco. Kevin has a M.S. degree in Biochemistry from the University of Missouri, Columbia and an A.B. degree, magna cum laude, in Molecular and Cell Biology from Cornell University.